These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3279580)

  • 1. The relationship between flow cytometer crossmatch results and subsequent rejection episodes in cadaver renal allograft recipients.
    Lazda VA; Pollak R; Mozes MF; Jonasson O
    Transplantation; 1988 Mar; 45(3):562-5. PubMed ID: 3279580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients.
    Christiaans MH; Overhof R; ten Haaft A; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 1996 Nov; 62(9):1341-7. PubMed ID: 8932282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of positive B cell flow cytometry crossmatch in predicting rejection among renal transplant recipients.
    Kotb M; Russell WC; Hathaway DK; Gaber LW; Gaber AO
    Clin Transplant; 1999 Feb; 13(1 Pt 2):83-9. PubMed ID: 10081642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-Cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients.
    Mahoney RJ; Taranto S; Edwards E
    Hum Immunol; 2002 Apr; 63(4):324-35. PubMed ID: 12039415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch.
    Lazda VA
    Transplantation; 1994 Mar; 57(6):964-9. PubMed ID: 8154047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
    Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
    Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreas transplantation in crossmatch-positive recipients.
    Khwaja K; Wijkstrom M; Gruessner A; Noreen H; Sutherland DE; Humar A; Kandaswamy R; Gruessner RW
    Clin Transplant; 2003 Jun; 17(3):242-8. PubMed ID: 12780675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival.
    Christiaans MH; Overhof-de Roos R; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 1998 Feb; 65(3):427-33. PubMed ID: 9484765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The flow cytometric crossmatch and early renal transplant loss.
    Mahoney RJ; Ault KA; Given SR; Adams RJ; Breggia AC; Paris PA; Palomaki GE; Hitchcox SA; White BW; Himmelfarb J
    Transplantation; 1990 Mar; 49(3):527-35. PubMed ID: 2138366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers in transplantation: Prospective, blinded measurement of predictive value for the flow cytometry crossmatch after negative antiglobulin crossmatch in kidney transplantation.
    Wen R; Wu V; Dmitrienko S; Yu A; Balshaw R; Keown PA;
    Kidney Int; 2006 Oct; 70(8):1474-81. PubMed ID: 16941026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive.
    Scornik JC; Clapp W; Patton PR; Van der Werf WJ; Hemming AW; Reed AI; Howard RJ
    Transplantation; 2001 Apr; 71(8):1098-102. PubMed ID: 11374409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients.
    Lorenz M; Regele H; Schillinger M; Kletzmayr J; Haidbauer B; Derfler K; Druml W; Böhmig GA
    Transplantation; 2005 Mar; 79(6):696-701. PubMed ID: 15785376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
    Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
    Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study.
    Opelz G; Döhler B; Süsal C
    Hum Immunol; 2009 Aug; 70(8):627-30. PubMed ID: 19375469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.
    Akalin E; Ames S; Sehgal V; Fotino M; Daly L; Murphy B; Bromberg JS
    Transplantation; 2003 Nov; 76(10):1444-7. PubMed ID: 14657683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.